tradingkey.logo

U.S. Court Of Appeals For The Federal Circuit Affirms Prior Delaware District Court Rulings In Favor Of Acadia In Nuplazid® (Pimavanserin) Composition Of Matter Patent

ReutersJun 9, 2025 8:03 PM

ACADIA Pharmaceuticals Inc ACAD.O:

  • U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT AFFIRMS PRIOR DELAWARE DISTRICT COURT RULINGS IN FAVOR OF ACADIA IN NUPLAZID® (PIMAVANSERIN) COMPOSITION OF MATTER PATENT

  • ACADIA PHARMACEUTICALS INC - NUPLAZID PATENT PROTECTION EXTENDED TO 2030

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI